Damian Garde

Joy Yang, Head of Index Product Management at MarketVector Indexes, shares her market outlook amidst turbulent trade negotiations and the potential for rate cuts. Damian Garde, Bloomberg Health Reporter, discusses Merck’s anticipated $200 million loss due to tariffs and the challenges facing its HPV vaccine, Gardasil, in the competitive Chinese market. They dive into the broader implications of tariffs on the pharmaceutical sector and how companies are navigating these financial hurdles.

Damian Garde, a Bloomberg News health reporter, dives into Eli Lilly's recent struggles as its new weight-loss pill disappoints, overshadowing a surge in its current obesity medication sales. He discusses the competitive landscape of weight-loss drugs and highlights the challenges of drug development. The conversation also touches on the broader impact on healthcare investments and the interplay between innovative treatments and market trends. Garde's insights paint a vivid picture of the fast-evolving pharmaceutical industry.

Damian Garde, a seasoned health reporter for Bloomberg News, dives into the transformative efforts of RFK Jr. in reshaping U.S. vaccine regulations. The discussion highlights the recent ACIP decision to endorse only thimerosal-free flu shots, aimed at addressing public concerns despite long-standing evidence of safety. Garde explores the implications for childhood vaccination guidelines and global vaccination funding, raising critical questions about the influence of political figures on public trust and health policy.